Literature DB >> 1658213

Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.

J A Garson1, M Lenzi, C Ring, F Cassani, G Ballardini, M Briggs, R S Tedder, F B Bianchi.   

Abstract

Sera from 14 patients with type 2 autoimmune hepatitis (anti-LKM1 positive) were investigated for evidence of hepatitis C virus (HCV) infection. Antibodies to HCV were detected in 13 patients by both commercial and "in-house" ELISAs and also by a second generation recombinant immunoblot assay. Nine of the 13 (69%) anti-HCV positive patients were shown to be viraemic by a polymerase chain reaction-based assay for serum HCV RNA. Neither anti-HCV nor serum HCV RNA were detected in any of 6 controls with primary biliary cirrhosis or in 39 healthy blood donors. These findings strongly suggest a role for HCV in the pathogenesis of type 2 autoimmune hepatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658213     DOI: 10.1002/jmv.1890340405

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

Review 1.  Immunological abnormalities and hepatotropic viral infections.

Authors:  I G McFarlane
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  The clinical virology of hepatitis C virus.

Authors:  W L Irving
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

Review 3.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

4.  Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.

Authors:  H Miyakawa; E Kitazawa; K Abe; N Kawaguchi; H Fuzikawa; K Kikuchi; M Kako; T Komatsu; N Hayashi; K Kiyosawa
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

5.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

Authors:  F Cassani; L Muratori; P Manotti; M Lenzi; M Fusconi; G Ballardini; L Selleri; U Volta; D Zauli; R Miniero
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

6.  Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.

Authors:  R Seelig; M Renz; G Bünger; H Schröter; H P Seelig
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

7.  Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.

Authors:  F B Bianchi; F Cassani; M Lenzi; G Ballardini; L Muratori; F Giostra; D Zauli
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 8.  Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.

Authors:  E D'Amico; M Paroli; V Fratelli; C Palazzi; V Barnaba; F Callea; G Consoli
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

Review 9.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

Authors:  G Ballardini; P Groff; P Pontisso; F Giostra; R Francesconi; M Lenzi; D Zauli; A Alberti; F B Bianchi
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.